Search results for "Dopamine"

showing 10 items of 660 documents

Relationship between prefrontal cognitive functions and dopaminergic transmission: A [18F]-fluoro-l-DOPA PET study

2006

NeurologyTransmission (telecommunications)ChemistryCognitive NeuroscienceDopaminergicCognitionNeuroscienceNeuroImage
researchProduct

Serotonin-dopamine interaction: electrophysiological evidence.

2008

In this review, the most relevant data regarding serotonin (5-hydroxytryptamine, 5-HT)/dopamine (DA) interaction in the brain, as studied by both in vivo and in vitro electrophysiological methods, are reported and discussed. The bulk of neuroanatomical data available clearly indicate that DA-containing neurons in the brain receive a prominent innervation from 5-HT originating in the raphe nuclei of the brainstem. Furthermore, this modulation seems to be reciprocal; DA neurons innervate the raphe nuclei and exert a tonic excitatory effect on them. Compelling electrophysiological data show that 5-HT can exert complex effects on the electrical activity of midbrain DA neurons mediated by the va…

NeuronsSerotoninDopamineBrainelectrophysiology dopamineSettore BIO/09 - FisiologiaElectric StimulationSerotonin Receptor AgonistsElectrophysiologyReceptors SerotoninDopamine AgonistsNeural PathwaysAnimalsDopamine AntagonistsSerotonin AntagonistsSelective Serotonin Reuptake InhibitorsProgress in brain research
researchProduct

Differentiation of Y79 cells induced by prolonged exposure to insulin

1997

Y79 human retinoblastoma cells are known to contain receptors for both insulin and insulin-like growth factors (IGFs), to produce these cytokines and release them in the culture medium. Previously we have demonstrated that IGFs and insulin stimulate Y79 cell proliferation through the involvement of type I IGF receptor and Insulin Receptor Substrate 1 (IRS-1). This paper studies the effect of prolonged exposure to insulin on Y79 cells. Cells grown for 10 days in the presence of insulin were reseeded and incubated once more with insulin. In the reseeded cells proliferation lowered and morphological changes appeared. After 10 days of reseeding, cells stopped proliferating and showed long ramif…

NeuronsTime FactorsEye NeoplasmsRetinoblastomaCell DifferentiationDNADopamine beta-HydroxylaseCholine O-AcetyltransferaseGlobinsDifferentiationGlial Fibrillary Acidic ProteinNeuritesTumor Cells CulturedHumansInsulinBiomarkersCell DivisionThymidine
researchProduct

Dopamine Interaction with other Neurotransmitter Systems: Relevance in the Pathophysiology and Treatment of CNS Disorders

2010

Neurotransmitter AgentsEditorialCentral Nervous System DiseasesDopamineBrainHumansSettore BIO/09 - Fisiologiadopamine neuropsychiatric disorders
researchProduct

Nitric Oxide Modulation of the Dopaminergic Nigrostriatal System: Focus on Nicotine Action

2009

Nitric oxide (NO) signalling plays an important role in the integration of information processed by the basal ganglia nuclei. Accordingly, considerable evidence has emerged indicating a role for NO in pathophysiological conditions such as Parkinson’s disease (PD), schizophrenia and drug addiction. To further investigate the NO modulation of dopaminergic function in the basal ganglia circuitry, in this study we used in vivo electrophysiology and microdialysis in freely-moving rats. Pharmacological manipulation of the NO system did not cause any significant changes either in the basal firing rate and bursting activity of the dopamine (DA) neurons in the substantia nigra pars compacta (SNc) or…

Nicotine addictionPars compactaChemistryDopamineDopaminergicNitric oxideSubstantia nigraStriatumSettore BIO/09 - FisiologiaNicotineGlobus pallidusnitric oxideDopaminebasal gangliaBasal gangliamedicinenigrostriatal pathwayNeurosciencedopaminergicnicotinemedicine.drug
researchProduct

Peripheral CB1 receptor blockade acts as a memory enhancer through an adrenergic-dependent mechanism

2021

Peripheral inputs to the brain continuously shape its function and can influence the formation of non-emotional memory, but the underlying mechanisms have not been fully understood. Cannabinoid type-1 receptors (CB1R), widely distributed in the organism, is a well-recognized player in memory performance, and its systemic modulation significantly influences memory function. By assessing non-emotional memory in mice, we have now found a relevant role of peripheral CB1R in the formation of persistent memory. Indeed, peripherally restricted CB1R antagonism by using AM6545 showed a mnemonic effect that was occluded in adrenalectomized mice, after peripheral adrenergic blockade, or when vagus ner…

NorepinephrineCannabinoid receptorDopamineChemistrymedicine.medical_treatmentmedicineAdrenergicLocus coeruleusCannabinoidHippocampal formationNeuroscienceBlockademedicine.drug
researchProduct

Heart rate variability during sleep in patients with schizophrenia treated with olanzapine.

2004

Cardiac adverse events in patients treated with atypical antipsychotics have gained increasing interest in recent years. In the present study, heart rate variability (HRV), which is a sensitive parameter reflecting central autonomic cardiac control, was investigated during treatment with olanzapine. Ten physically healthy male patients with schizophrenia, who displayed predominantly negative symptoms, were studied in the sleep laboratory under drug-free baseline conditions and after 4 weeks of olanzapine medication. HRV was assessed during different sleep stages both in the time and frequency domains. Only slight changes in HRV were shown during treatment, and appeared to be independent of …

OlanzapineAdultMalePsychosisAdolescentmedicine.drug_classAtypical antipsychoticBenzodiazepinesHeart RateHeart ratemedicineHeart rate variabilityHumansPharmacology (medical)Sleep StagesDose-Response Relationship DrugDopamine antagonistElectroencephalographymedicine.diseasePsychiatry and Mental healthSchizophreniaOlanzapineAnesthesiaSchizophreniaSleep StagesPsychologymedicine.drugAntipsychotic AgentsInternational clinical psychopharmacology
researchProduct

Fluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacokinetic interactions and clinical effects.

2002

Olanzapine is a substrate of the cytochrome P450 enzyme (CYP) 1A2. In this study, pharmacokinetic interactions and clinical effects of adding the CYP1A2 inhibitor fluvoxamine to steady-state olanzapine was examined in patients suffering from schizophrenia. Eight patients had been treated for at least 3 months with 10 to 20 mg/day olanzapine. Fluvoxamine (100 mg/day) was added (week 0) to the olanzapine treatment and continued for 8 weeks. Concentrations of olanzapine and its metabolite N-desmethylolanzapine and of fluvoxamine were analyzed at weeks 0, 1, 4, and 8. Addition of fluvoxamine resulted in a 12% to 112% (0.01) increase of olanzapine from 31 +/- SD 15 ng/mL (week 0) to 56 +/- 31 ng…

OlanzapineAdultMaleTime FactorsCombination therapyFluvoxaminePharmacologyBenzodiazepinesPharmacokineticsmedicineHumansPharmacology (medical)Drug InteractionsProspective Studiesmedicine.diagnostic_testbusiness.industryDopamine antagonistPirenzepineDrug interactionMiddle AgedPsychiatry and Mental healthTherapeutic drug monitoringChemotherapy AdjuvantFluvoxamineOlanzapineChronic DiseaseSchizophreniaFemalebusinessReuptake inhibitorSelective Serotonin Reuptake Inhibitorsmedicine.drugFollow-Up StudiesJournal of clinical psychopharmacology
researchProduct

Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine.

2005

Summary Nocturnal hormone profiles were measured in patients with schizophrenia with predominantly negative symptoms both under drug-free baseline conditions and after subchronic administration of the atypical antipsychotic olanzapine, with the aim of characterizing its pharmacological properties on the neuroendocrine level. The following hormones were studied in the sleep laboratory under polysomnographic control: adrenocorticotrophic hormone, cortisol, growth hormone (GH), prolactin, testosterone, and melatonin. Blood samples were taken at regular time intervals over the night, and serum concentrations of the hormones were determined. Ten patients completed the study, two of them were exc…

OlanzapineAdultMalemedicine.medical_specialtyHydrocortisonemedicine.drug_classEndocrinology Diabetes and MetabolismAtypical antipsychoticMelatoninBenzodiazepinesEndocrinologyAdrenocorticotropic HormoneInternal medicinemedicineHumansTestosteroneCircadian rhythmBiological PsychiatryTestosteroneMelatoninInpatientsEndocrine and Autonomic SystemsDopamine antagonistProlactinCircadian RhythmProlactinPsychiatry and Mental healthEndocrinologyOlanzapineGrowth HormoneSchizophreniaPsychologySleepmedicine.drugHormoneAntipsychotic AgentsPsychoneuroendocrinology
researchProduct

Bilateral olfactory deprivation reveals a selective noradrenergic regulatory input to the olfactory bulb.

2001

Unilateral olfactory deprivation in the rat induces changes in the catecholaminergic system of the olfactory bulb. Nevertheless, evidence suggests that unilateral deprivation does not fully prevent stimulation of the deprived bulb. The present report analyses the response of the catecholaminergic system of the olfactory bulb in fully deprived rats obtained by bilateral naris occlusion. The complete deprivation produces more rapid and dramatic changes in both the intrinsic and extrinsic catecholaminergic systems of the olfactory bulb. Intrinsic responses involve a rapid decrease in dopamine-containing cells to about 25% of controls, correlated with a decreased Fos expression in juxtaglomerul…

Olfactory systemOlfactory NerveTyrosine 3-MonooxygenaseDopamineCentral nervous systemOlfactionDopamine beta-HydroxylaseBiologyNorepinephrinemedicineAnimalsSensory deprivationOlfactory memoryRats WistarCatecholaminergicAfferent PathwaysNeuronal PlasticityGeneral NeuroscienceOlfactory tubercleDenervationOlfactory BulbAxonsOlfactory bulbRatsSmellOlfactory Nerve Injuriesmedicine.anatomical_structureFemaleLocus CoeruleusSensory DeprivationNeuroscienceProto-Oncogene Proteins c-fosNeuroscience
researchProduct